Published in J Neurol Sci on September 17, 2009
Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsychopharmacology (2011) 1.21
Thalamic stimulation to improve level of consciousness after seizures: evaluation of electrophysiology and behavior. Epilepsia (2014) 1.00
The pedunculopontine nucleus as a target for deep brain stimulation. J Neural Transm (Vienna) (2010) 0.92
The effects of deep brain stimulation on sleep in Parkinson's disease. Ther Adv Neurol Disord (2011) 0.91
Cholinergic and non-cholinergic mesopontine tegmental neurons projecting to the subthalamic nucleus in the rat. Eur J Neurosci (2010) 0.91
Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up. Sleep (2012) 0.89
The physiology of the pedunculopontine nucleus: implications for deep brain stimulation. J Neural Transm (Vienna) (2014) 0.89
The serendipity case of the pedunculopontine nucleus low-frequency brain stimulation: chasing a gait response, finding sleep, and cognition improvement. Front Neurol (2013) 0.86
Cognitive activation by central thalamic stimulation: the yerkes-dodson law revisited. Dose Response (2010) 0.86
Neural mechanisms and potential treatment of epilepsy and its complications. Am J Transl Res (2014) 0.86
The pedunculopontine tegmental nucleus-A functional hypothesis from the comparative literature. Mov Disord (2016) 0.82
The treatment of Parkinson's disease with deep brain stimulation: current issues. Neural Regen Res (2015) 0.82
Deep brain stimulation of different pedunculopontine targets in a novel rodent model of parkinsonism. J Neurosci (2015) 0.81
Neural circuitry for behavioural arrest. Philos Trans R Soc Lond B Biol Sci (2017) 0.78
Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease. Mol Neurodegener (2015) 0.78
Arousal and the control of perception and movement. Curr Trends Neurol (2016) 0.76
Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease. Oman Med J (2015) 0.76
Neurophysiological evaluation of the pedunculopontine nucleus in humans. J Neural Transm (Vienna) (2011) 0.76
Pedunculopontine arousal system physiology - Deep brain stimulation (DBS). Sleep Sci (2015) 0.76
Arousal, motor control, and parkinson's disease. Transl Neurosci (2015) 0.75
Network effects of deep brain stimulation. J Neurophysiol (2015) 0.75
Pathological gambling from dopamine agonist and deep brain stimulation of the nucleus tegmenti pedunculopontine. BMJ Case Rep (2010) 0.75
Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's disease. Mol Ther Methods Clin Dev (2016) 0.75
Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson's disease. Neurosci Bull (2014) 0.75
Deep Brain Stimulation in Parkinson's Disease: New and Emerging Targets for Refractory Motor and Nonmotor Symptoms. Parkinsons Dis (2017) 0.75
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain (2007) 4.13
Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport (2005) 3.80
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord (2009) 3.56
Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women. J Natl Cancer Inst (2003) 3.20
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy. J Natl Cancer Inst (2009) 2.77
Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2. Clin Cancer Res (2004) 2.77
International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? J Natl Cancer Inst (2010) 2.28
MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease. Radiology (2014) 2.14
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain (2010) 2.01
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. Circulation (2005) 2.01
Dopamine agonists and delusional jealousy in Parkinson's disease: a cross-sectional prevalence study. Mov Disord (2012) 1.98
Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy. J Natl Cancer Inst (2007) 1.97
Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2. Cancer Res (2007) 1.88
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res Treat (2007) 1.82
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. Parkinsonism Relat Disord (2007) 1.72
Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Diabetes Care (2003) 1.72
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur J Hum Genet (2005) 1.71
Sleep-related changes in baroreflex sensitivity and cardiovascular autonomic modulation. J Hypertens (2003) 1.58
Cognitive profile and brain morphological changes in obstructive sleep apnea. Neuroimage (2010) 1.53
Association between amantadine and the onset of dementia in Parkinson's disease. Mov Disord (2006) 1.50
Apoptosis induction by trastuzumab: possible role of the core biopsy intervention. J Clin Oncol (2005) 1.49
Cyclic vomiting syndrome, migraine, and epilepsy: a common underlying disorder? Headache (2003) 1.47
Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage. Am J Cardiol (2009) 1.46
Effects of deep brain stimulation of the peduncolopontine area on working memory tasks in patients with Parkinson's disease. Parkinsonism Relat Disord (2009) 1.45
Increased cortical excitability after selective REM sleep deprivation in healthy humans: a transcranial magnetic stimulation study. Sleep Med (2013) 1.43
Diagnosis, assessment and management of delusional jealousy in Parkinson's disease with and without dementia. Neurol Sci (2012) 1.39
[Mechanism of troponin and CK-MB release after percutaneous coronary interventions]. Ital Heart J Suppl (2002) 1.39
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease. Parkinsonism Relat Disord (2012) 1.39
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. J Neurol (2012) 1.34
Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke (2002) 1.22
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. Sleep (2008) 1.22
Necrotic complications after nipple- and areola-sparing mastectomy. World J Surg (2006) 1.21
Functional changes in the activity of cerebellum and frontostriatal regions during externally and internally timed movement in Parkinson's disease. Brain Res Bull (2006) 1.20
Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.20
A molecular signature in blood identifies early Parkinson's disease. Mol Neurodegener (2012) 1.13
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology (2014) 1.13
Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: long-term results. Int J Cancer (2005) 1.13
Impaired reproduction of second but not millisecond time intervals in Parkinson's disease. Neuropsychologia (2007) 1.10
Delayed nipple-sparing modified subcutaneous mastectomy: rationale and technique. Breast J (2005) 1.10
The requirements of a specialist Prostate Cancer Unit: a discussion paper from the European School of Oncology. Eur J Cancer (2010) 1.10
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease. J Neuroinflammation (2012) 1.08
Impulsivity and compulsivity in drug-naïve patients with Parkinson's disease. Mov Disord (2011) 1.08
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics. Epilepsia (2014) 1.07
Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population. Neurol Sci (2012) 1.07
PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. Hum Mutat (2008) 1.06
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol (2009) 1.05
Prospective memory impairment in individuals with Parkinson's disease. Neuropsychology (2008) 1.04
Dopaminergic modulation of visual-spatial working memory in Parkinson's disease. Dement Geriatr Cogn Disord (2003) 1.00
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease. Eur J Neurosci (2006) 0.99
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment. J Neurol Sci (2006) 0.98
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients. Ann Neurol (2005) 0.97
A systematic review of catechol-0-methyltransferase inhibitors: efficacy and safety in clinical practice. Clin Neuropharmacol (2012) 0.96
Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels. Eur J Radiol (2008) 0.96
Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients. Ann Neurol (2005) 0.95
Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease. J Neurosurg (2004) 0.95
Orthostatic hypotension in de novo Parkinson disease. Arch Neurol (2003) 0.94
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease. Exp Neurol (2003) 0.94
Successful publishing: how to get your paper accepted. Surg Oncol (2008) 0.93
The golden ratio of gait harmony: repetitive proportions of repetitive gait phases. Biomed Res Int (2013) 0.93
Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory. Neuropsychologia (2009) 0.93
Decision making in de novo Parkinson's disease. Mov Disord (2010) 0.92
CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia. J Neurol Sci (2009) 0.92
Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex. Brain Res Bull (2008) 0.92
Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling. Circulation (2002) 0.92
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer. Breast Cancer Res Treat (2010) 0.91
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. J Neurol Sci (2005) 0.90
Relation of low bone mineral density and carotid atherosclerosis in postmenopausal women. Am J Cardiol (2004) 0.90
Baroreflex buffering of sympathetic activation during sleep: evidence from autonomic assessment of sleep macroarchitecture and microarchitecture. Hypertension (2004) 0.90
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations. Mov Disord (2009) 0.90
Late-onset MNGIE without peripheral neuropathy due to incomplete loss of thymidine phosphorylase activity. Neuromuscul Disord (2009) 0.89
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-naïve patients with Parkinson's disease. J Clin Exp Neuropsychol (2012) 0.89
123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms. Nucl Med Commun (2005) 0.89
Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up. Sleep (2012) 0.89